Reprimand to Medical Prognosis Institute


Disclosure of information to the press

Nasdaq Copenhagen reprimanded Medical Prognosis Institute A/S that the company’s management had provided the press with information without this information being disclosed to the market simultaneously in accordance with First North Rulebook rule 4.1 (a.). 

 

The complete decision is available in Decisions & Statements on the following link:

http://www.nasdaqomx.com/listing/europe/surveillance/copenhagen/

 

In order to ensure more transparency about the decisions from the exchange, decisions made by the exchange concerning a reprimand or a fine are published with the identity of the issuer. Sanctions of rule breaches on First North shows from the First North Rulebook rule 7.2.1 (e) and rule 7.1 (c). If a company, admitted to trading on First North, breaches the rules, the exchange can give a reprimand to the company, which the exchange shall publish. If a Certified Adviser breaches the rules, the exchange can give a reprimand to the Certified Adviser, which the exchange can publish.

 

 

 

For further information, please contact: Pernille Gram, Surveillance, tel. 33 93 33 66

 

 

 


Attachments

A&U meddelelse_uk_juli 2015 - Medical Prognosis Institute.pdf